Sharing this announcement -
NHLBI Biostatistics Workshop on Clinical Trial Designs: Innovative Endpoints and Futility Monitoring
The Office of Biostatistics Research (OBR) at the National Heart, Lung, and Blood Institute will host a two-day workshop on September 18-19, 2023 at Natcher Conference Center, NIH Main Campus, Bethesda, Maryland.
This workshop intends to address two main design issues for the randomized clinical trials: (a) selection of clinically meaningful endpoints, and (b) appropriate futility monitoring.
The topics include:
· Statistical Methods for Endpoint Choices
· Endpoints in Cardiovascular Diseases
· Endpoints in Blood and Lung Diseases
· Logistics for Statistical Futility Monitoring
· Statistical Methods for Futility Monitoring
· Case Studies for Futility Monitoring
This workshop will bring together distinguished experts from the academia, industry, and US federal government (FDA and NIH) to share their insights and solutions to these issues. The conference should be of particular interest to biostatisticians, clinical trialists, medical researchers and clinicians.
This workshop is free (registration required), and it is open to the public. You can participate in the workshop either in-person, or virtually via Zoom. For more information, please click on the following link: https://www.nhlbi.nih.gov/events/2023/nhlbi-biostatistics-workshop-clinical-trial-designs-innovative-endpoints-and-futility
For registration, https://www.eventbrite.com/e/663908366797
For inquiries, please contact Ms. Barbara Bloomquist (barbara.bloomquist@nih.gov).
Dong-Yun Kim, Ph.D., Co-chair
Colin Wu, Ph.D., Co-chair
OBR Workshop Organizing Committee
Office of Biostatistics Research (OBR)
National Heart, Lung, and Blood Institute
------------------------------
Donna LaLonde
Pronouns: she, her, hers
Associate Executive Director
American Statistical Association
------------------------------